Skip to main content

Beren Therapeutics

Thousand Oaks, United States

Beren Therapeutics is a biotechnology company that develops innovative therapies to make them accessible to every patient.

$165.0M raised
Jun 2026
Debt Financing

Founder Contacts

30,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Beren Therapeutics

How much funding has Beren Therapeutics raised?
Beren Therapeutics has raised $165.0M in total funding. The most recent round was Debt Financing. The last funding was announced in June 2026.
Who are Beren Therapeutics's investors?
Beren Therapeutics's investors include Founders Fund, Gaingels, JIC Venture Growth Investments, Wellington Partners, Narya Capital.
Where is Beren Therapeutics headquartered?
Beren Therapeutics is headquartered in Thousand Oaks, United States.
What does Beren Therapeutics do?
Beren Therapeutics is a biotechnology company that develops innovative therapies to make them accessible to every patient.
What stage is Beren Therapeutics at?
Beren Therapeutics is at the Debt Financing stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Beren Therapeutics — Funding & Investors." VCBacked, June 10, 2026, https://www.vcbacked.co/company/beren-therapeutics. Accessed July 1, 2026.
APA
VCBacked. (2026). Beren Therapeutics — Funding & Investors. Retrieved July 1, 2026, from https://www.vcbacked.co/company/beren-therapeutics
Wikipedia (cite web)
{{cite web |title=Beren Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/beren-therapeutics |website=VCBacked |access-date=July 1, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .